SORBENT REMOVAL OF ANTI-CANCER DRUGS

被引:0
|
作者
RAHMAN, A
WINCHESTER, JF
KESSLER, A
SLAVIK, M
SCHEIN, P
机构
[1] GEORGE WASHINGTON UNIV,SCH MED,VINCENT T LOMBARDI CANC RES CTR,DIV MED ONCOL,WASHINGTON,DC 20007
[2] GEORGE WASHINGTON UNIV,SCH MED,DIV NEPHROL,WASHINGTON,DC 20007
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:233 / 233
页数:1
相关论文
共 50 条
  • [31] ACCESS TO EXPENSIVE ANTI-CANCER DRUGS
    Sullivan, Danny
    Mileshkin, Linda
    JOURNAL OF LAW AND MEDICINE, 2011, 19 (02) : 232 - 243
  • [32] Phosphodiesterase inhibitors as anti-cancer drugs
    Hirsh, L
    Dantes, A
    Suh, BS
    Yoshida, Y
    Hosokawa, K
    Tajima, K
    Kotsuji, F
    Merimsky, O
    Amsterdam, A
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 981 - 988
  • [33] SRC as a target for anti-cancer drugs
    Levitzki, A
    ANTI-CANCER DRUG DESIGN, 1996, 11 (03): : 175 - 182
  • [34] PROBLEMS OF TOXICITY OF ANTI-CANCER DRUGS
    YOUNG, RSK
    FEDERATION PROCEEDINGS, 1979, 38 (01) : 113 - 114
  • [35] Optional copayments on anti-cancer drugs
    van de Vooren, Katelijne
    Curto, Alessandro
    Garattini, Livio
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [36] PHARMACOKINETICS OF ANTI-CANCER DRUGS IN CHILDREN
    EVANS, WE
    CROM, WR
    SINKULE, JA
    YEE, GC
    STEWART, CF
    HUTSON, PR
    DRUG METABOLISM REVIEWS, 1983, 14 (05) : 847 - 886
  • [37] Liposomal encapsulated anti-cancer drugs
    Hofheinz, RD
    Gnad-Vogt, SU
    Beyer, U
    Hochhaus, A
    ANTI-CANCER DRUGS, 2005, 16 (07) : 691 - 707
  • [38] Tissue transport of anti-cancer drugs
    Lankelma, J
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (22) : 1987 - 1993
  • [39] Taxanes: Promising Anti-Cancer Drugs
    Fauzee, Nilufer Jasmine Selimah
    Dong, Zhi
    Wang, Ya-lan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 837 - 851
  • [40] Anaesthesia and anti-cancer chemotherapeutic drugs
    Huettemann, Egbert
    Sakka, Samir G.
    CURRENT OPINION IN ANESTHESIOLOGY, 2005, 18 (03) : 307 - 314